Quick Answer
ONCOLYTICS BIOTECH INC reported Operating Income of -$28.73 million for fiscal year 2025.
ONCOLYTICS BIOTECH INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$28.73M | -12.5% |
| 2024 | -$25.54M | — |
- ONCOLYTICS BIOTECH INC showed a decrease of -12.5% in Operating Income compared to the prior fiscal year.
- Over the 2024–2025 period, ONCOLYTICS BIOTECH INC’s operating income has declined by 12.5% (from -$25.54 million to -$28.73 million).
- The most recent figure is from ONCOLYTICS BIOTECH INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: